These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 33949487)
1. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells. Lin M; Zou S; Liao X; Chen Y; Luo D; Ji L; Chao H Chem Commun (Camb); 2021 May; 57(36):4408-4411. PubMed ID: 33949487 [TBL] [Abstract][Full Text] [Related]
2. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers. Mo J; Mai Le NP; Priefer R Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979 [TBL] [Abstract][Full Text] [Related]
3. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity. Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972 [TBL] [Abstract][Full Text] [Related]
4. A novel ruthenium polypyridyl complex for the selective imaging and photodynamic targeting of the Golgi apparatus. Zhao F; Wang W; Wu W Dalton Trans; 2021 Mar; 50(10):3536-3541. PubMed ID: 33599670 [TBL] [Abstract][Full Text] [Related]
5. A Multi-action and Multi-target Ru Karges J; Yempala T; Tharaud M; Gibson D; Gasser G Angew Chem Int Ed Engl; 2020 Apr; 59(18):7069-7075. PubMed ID: 32017379 [TBL] [Abstract][Full Text] [Related]
6. Rational design of type I photosensitizers based on Ru(ii) complexes for effective photodynamic therapy under hypoxia. Liu X; Li G; Xie M; Guo S; Zhao W; Li F; Liu S; Zhao Q Dalton Trans; 2020 Aug; 49(32):11192-11200. PubMed ID: 32748922 [TBL] [Abstract][Full Text] [Related]
7. The stepwise photodamage of organelles by two-photon luminescent ruthenium(ii) photosensitizers. Qiu K; Wen Y; Ouyang C; Liao X; Liu C; Rees TW; Zhang Q; Ji L; Chao H Chem Commun (Camb); 2019 Sep; 55(75):11235-11238. PubMed ID: 31469153 [TBL] [Abstract][Full Text] [Related]
8. A biotinylated ruthenium(ii) photosensitizer for tumor-targeted two-photon photodynamic therapy. Li J; Zeng L; Xiong K; Rees TW; Jin C; Wu W; Chen Y; Ji L; Chao H Chem Commun (Camb); 2019 Sep; 55(73):10972-10975. PubMed ID: 31453611 [TBL] [Abstract][Full Text] [Related]
9. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy. Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic antitumor activity of Ru(ii) complexes of imidazo-phenanthroline conjugated hydroxybenzoic acid as tumor targeting photosensitizers. Liu ZY; Zhang J; Sun YM; Zhu CF; Lu YN; Wu JZ; Li J; Liu HY; Ye Y J Mater Chem B; 2020 Jan; 8(3):438-446. PubMed ID: 31833531 [TBL] [Abstract][Full Text] [Related]
12. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells. Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841 [TBL] [Abstract][Full Text] [Related]
13. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers. Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123 [TBL] [Abstract][Full Text] [Related]
14. Rational design of a red-light absorbing ruthenium polypyridine complex as a photosensitizer for photodynamic therapy. Fennes A; Montesdeoca N; Papadopoulos Z; Karges J Chem Commun (Camb); 2024 Sep; 60(77):10724-10727. PubMed ID: 39240534 [TBL] [Abstract][Full Text] [Related]
15. Increased Lipophilicity of Halogenated Ruthenium(II) Polypyridyl Complexes Leads to Decreased Phototoxicity in vitro when Used as Photosensitizers for Photodynamic Therapy. Roy S; Colombo E; Vinck R; Mari C; Rubbiani R; Patra M; Gasser G Chembiochem; 2020 Oct; 21(20):2966-2973. PubMed ID: 32473056 [TBL] [Abstract][Full Text] [Related]
16. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands. Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A Eur J Med Chem; 2024 Oct; 276():116618. PubMed ID: 38972079 [TBL] [Abstract][Full Text] [Related]
17. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells. Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527 [TBL] [Abstract][Full Text] [Related]
18. An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells. Zhao X; Li M; Sun W; Fan J; Du J; Peng X Chem Commun (Camb); 2018 Jun; 54(51):7038-7041. PubMed ID: 29873358 [TBL] [Abstract][Full Text] [Related]
19. Bombesin-Targeted Delivery of β-Carboline-Based Ir(III) and Ru(II) Photosensitizers for a Selective Photodynamic Therapy of Prostate Cancer. Sanz-Villafruela J; Bermejo-Casadesús C; Riesco-Llach G; Iglesias M; Martínez-Alonso M; Planas M; Feliu L; Espino G; Massaguer A Inorg Chem; 2024 Oct; 63(41):19140-19155. PubMed ID: 39361042 [TBL] [Abstract][Full Text] [Related]
20. A GSH-activatable ruthenium(ii)-azo photosensitizer for two-photon photodynamic therapy. Zeng L; Kuang S; Li G; Jin C; Ji L; Chao H Chem Commun (Camb); 2017 Feb; 53(12):1977-1980. PubMed ID: 28119967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]